4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000169
Chairperson & CEO sold 9,500 shares at an average $560.07 ($5,320,681)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-21 | Sale : show line 2 in the form 10b5-1 | −46 | $552.52 | $25,416 | 333,897 | I |
| 2026-10-21 | Sale : show line 3 in the form 10b5-1 | −194 | $553.78 | $107,434 | 333,703 | I |
| 2026-10-21 | Sale : show line 4 in the form 10b5-1 | −550 | $555.19 | $305,357 | 333,153 | I |
| 2026-10-21 | Sale : show line 5 in the form 10b5-1 | −567 | $556.41 | $315,486 | 332,586 | I |
| 2026-10-21 | Sale : show line 6 in the form 10b5-1 | −1,702 | $557.25 | $948,432 | 330,884 | I |
| 2026-10-21 | Sale : show line 7 in the form 10b5-1 | −1,137 | $558.32 | $634,808 | 329,747 | I |
| 2026-10-21 | Sale : show line 8 in the form 10b5-1 | −743 | $559.25 | $415,521 | 329,004 | I |
| Open-market sales · 9,500 sh · avg $560.07 · $5,320,681 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-21 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −9,500 | 185,910 | I |
Loading xslF345X06/primarydocument.xml…